Open AccessTherapeutic Opportunity in Innate Immune Response Induction by Oncogene-Targeted Drugs
Author(s) -
Daniel J Sisler,
Lynn E. Heasley
Publication year - 2019
Publication title -
future medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.708
H-Index - 69
eISSN - 1756-8927
pISSN - 1756-8919
DOI - 10.4155/fmc-2018-0292
Subject(s) - cancer research , cancer , innate immune system , biology , crizotinib , receptor tyrosine kinase , aurora kinase , targeted therapy , tyrosine kinase , immune system , immunology , kinase , medicine , lung cancer , oncology , signal transduction , genetics , cell cycle , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom